Medtech company Stryker recorded $6 billion in consolidated net sales in the first quarter of 2026, a 2.6% increase, according to its financial results published April 30.
Here are four more earnings notes:
- MedSurg and Neurotechnology accounted for $3.2 billion of net sales and orthopedics accounted for $2.8 billion.
- Overall organic sales increased 2.4%, driven by 4.1% increase in orthopedics and a 0.9% increase in MedSurg and Neurotechnology.
- Stryker’s net earnings of $745 million in the first quarter of 2026 is a 13.9% increase.
- The company is maintaining its previous projections of organic net sales growth to be between 8 and 9.5%.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
